These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29419686)

  • 1. The clinical efficacy of epalrestat combined with α-lipoic acid in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis.
    Wang X; Lin H; Xu S; Jin Y; Zhang R
    Medicine (Baltimore); 2018 Feb; 97(6):e9828. PubMed ID: 29419686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy.
    Wang X; Lin H; Xu S; Jin Y; Zhang R
    Drug Des Devel Ther; 2018; 12():2827-2840. PubMed ID: 30233145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of epalrestat plus α-lipoic acid combination therapy
    Zhao M; Chen JY; Chu YD; Zhu YB; Luo L; Bu SZ
    Neural Regen Res; 2018 Jun; 13(6):1087-1095. PubMed ID: 29926837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoic Acid Combined with Epalrestat versus Lipoic Acid in Treating Diabetic Peripheral Neuropathy:A Meta-analysis.
    Wang XT; Lin HX; Xu SA; Lu YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):656-664. PubMed ID: 29125108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials.
    Ran GL; Li YP; Lu LC; Lan SH
    J Diabetes Complications; 2024 Feb; 38(2):108691. PubMed ID: 38330524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy.
    Han T; Bai J; Liu W; Hu Y
    Eur J Endocrinol; 2012 Oct; 167(4):465-71. PubMed ID: 22837391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat.
    Hotta N; Kawamori R; Atsumi Y; Baba M; Kishikawa H; Nakamura J; Oikawa S; Yamada N; Yasuda H; Shigeta Y;
    Diabet Med; 2008 Jul; 25(7):818-25. PubMed ID: 18644069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial.
    Hotta N; Akanuma Y; Kawamori R; Matsuoka K; Oka Y; Shichiri M; Toyota T; Nakashima M; Yoshimura I; Sakamoto N; Shigeta Y
    Diabetes Care; 2006 Jul; 29(7):1538-44. PubMed ID: 16801576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and safety of alprostadil combined with alpha lipoic acid in the treatment of diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis.
    Guan H; Ye M; Fang C; Zhang L; Han P; Qiu S; Fang X; Li L
    Medicine (Baltimore); 2020 Dec; 99(50):e23507. PubMed ID: 33327292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasudil combined with methylcobalamin or lipoic acid can improve the nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis.
    Jiang DQ; Xu LC; Jiang LL; Li MX; Wang Y
    Medicine (Baltimore); 2018 Jul; 97(27):e11390. PubMed ID: 29979431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.
    Ramirez MA; Borja NL
    Pharmacotherapy; 2008 May; 28(5):646-55. PubMed ID: 18447661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Danggui Sini decoction for treating diabetic peripheral neuropathy: A protocol of systematic review and meta-analysis of randomized controlled trials.
    Zhang X; Wang H; Zhang Y; Liu Y; Wang Z; Du Q; Xie C
    Medicine (Baltimore); 2020 May; 99(21):e20482. PubMed ID: 32481353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional Chinese medicine fumigation as auxiliary treatment of diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis.
    Kang S; Zhong Y; Liu D; Li W
    Medicine (Baltimore); 2021 Jan; 100(4):e24200. PubMed ID: 33530212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huangqi Guizhi Wuwu decoction for diabetic peripheral neuropathy: Protocol for a systematic review.
    Zhang Y; Gong G; Zhang X; Zhou L; Xie H; Tian Y; Xie C
    Medicine (Baltimore); 2019 Aug; 98(31):e16696. PubMed ID: 31374060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
    Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
    Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of prostaglandin E1 plus lipoic acid combination therapy versus monotherapy for patients with diabetic peripheral neuropathy.
    Jiang DQ; Li MX; Ma YJ; Wang Y; Wang Y
    J Clin Neurosci; 2016 May; 27():8-16. PubMed ID: 26775115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of photobiomodulation therapy in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis.
    Fan X; Yan G; Cao J; Zhao Y; Wang Y; Wang X; Mi J
    PLoS One; 2024; 19(8):e0308537. PubMed ID: 39186566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systematic review and Meta-analysis of efficacy and safety of Shuxuetong Injection in treatment of diabetic peripheral neuropathy].
    Li X; Li B; Wang TY; Wang H; Li Q
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(11):3088-3094. PubMed ID: 35718533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy.
    Hotta N; Kawamori R; Fukuda M; Shigeta Y;
    Diabet Med; 2012 Dec; 29(12):1529-33. PubMed ID: 22507139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of Buyang Huanwu decoction for diabetic peripheral neuropathy: a systematic review and Metaanalysis.
    Meizhen Z; Xiaohui H; Yiting T; Yupeng C; Puyu HE; Liming Z; Bing P; Qing NI
    J Tradit Chin Med; 2023 Oct; 43(5):841-850. PubMed ID: 37679971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.